COMP <GO>
ABCL vs DNTH // 10Y YIELD & FRED MACRO BETA
AbCellera Biologics Inc. (NASDAQ) VS. Dianthus Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ABCL 3
— DNTH 3
■ METRIC PARITY
LAST: $11.12 (-9.37%) • MKT CAP: $3.97B
macro-sensitivity
—
LAST: $82.25 (-0.16%) • MKT CAP: $4.61B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABCL VS. DNTH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ABCL | DNTH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -20.50% | -30.70% | +10.20 | ABCL | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.11% | -2.79% | -1.32 | DNTH | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 160.60% | -65.00% | +225.60 | ABCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.60 | 26.00 | -19.40 | DNTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 46.8 | +2.20 | ABCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 20.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.97B | $4.61B | -$633.6M | DNTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ABCL REV | DNTH REV | ABCL GROSS % | DNTH GROSS % | ABCL FCF | DNTH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $75.1M | $2.0M | — | — | -$174.1M | -$129.2M |
| FY 2024 | $28.8M | $6.2M | — | — | -$187.0M | -$78.5M |
| FY 2023 | $38.0M | $2.8M | — | — | -$43.9M | -$37.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABCL // BETA —
DNTH // BETA 1.08